Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 May 6:9:e57239.
doi: 10.7554/eLife.57239.

Encouraging cartilage production

Affiliations
Comment

Encouraging cartilage production

H Scott Stadler. Elife. .

Abstract

A long non-coding RNA called GRASLND is essential to help stem cells create stable cartilage.

Keywords: human; mesenchymal stem cells; regenerative medicine; rnf144a-as1; stem cells; tissue engineering.

PubMed Disclaimer

Conflict of interest statement

HS No competing interests declared

Figures

Figure 1.
Figure 1.. GRASLND helps mesenchymal stem cells to create cartilage by suppressing IFN-signaling.
(A) Exposing mesenchymal stem cells (MSCs) to the growth factor TGFβ3 activates the expression of the Sox9 gene, which triggers the production of a long non-coding RNA called GRASLND. (B) GRASLND binds to the kinase EIF2AK2 (blue), which blocks the inhibitory phosphorylation of the protein EIF2A (green). This, in turn, promotes the expression of 'prochondrogenic factors' that encourage the production of molecules, such as proteoglycans, which form cartilage; the cell is said to have a 'chondrogenic' phenotype. (C) When GRASLND is depleted from mesenchymal stem cells, the kinase EIF2AK2 probably phosphorylates EIF2A (represented here by the ‘-P*’). This activates the Type II IFN-γ response, which ultimately leads to a reduction in proteoglycan expression and a loss of the chondrogenic phenotype. GRASLND: glycosaminoglycan regulatory associated long non-coding RNA; EIF2A: eukaryotic translation initiation factor two alpha; EIF2AK2: EIF2A kinase; TGFβ3: transforming growth factor beta 3. Figure created using BioRender (BioRender.com).

Comment on

References

    1. Barter MJ, Gomez R, Hyatt S, Cheung K, Skelton AJ, Xu Y, Clark IM, Young DA. The long non-coding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells. Development. 2017;144:4510–4521. doi: 10.1242/dev.152504. - DOI - PMC - PubMed
    1. Bugbee WD, Pallante-Kichura AL, Görtz S, Amiel D, Sah R. Osteochondral allograft transplantation in cartilage repair: graft storage paradigm, translational models, and clinical applications. Journal of Orthopaedic Research. 2016;34:31–38. doi: 10.1002/jor.22998. - DOI - PMC - PubMed
    1. Duque G, Huang DC, Dion N, Macoritto M, Rivas D, Li W, Yang XF, Li J, Lian J, Marino FT, Barralet J, Lascau V, Deschênes C, Ste-Marie LG, Kremer R. Interferon-γ plays a role in bone formation in vivo and rescues osteoporosis in ovariectomized mice. Journal of Bone and Mineral Research. 2011;26:1472–1483. doi: 10.1002/jbmr.350. - DOI - PubMed
    1. Hootman JM, Helmick CG, Barbour KE, Theis KA, Boring MA. Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015-2040. Arthritis & Rheumatology. 2016;68:1582–1587. doi: 10.1002/art.39692. - DOI - PMC - PubMed
    1. Huynh NPT, Zhang B, Guilak F. High‐depth transcriptomic profiling reveals the temporal gene signature of human mesenchymal stem cells during chondrogenesis. The FASEB Journal. 2019;33:358–372. doi: 10.1096/fj.201800534R. - DOI - PMC - PubMed